Patent Assignment Assignor Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
Assignor Name :
SERREAU, SEVERINE
|
|
Total Assignments:
3
|
|
Assignment:
1
|
| |
|
| Reel/Frame: | 019482/0581 | |
| Pages: | 5 |
| | Recorded: | 06/13/2007 | | |
| Attorney Dkt #: | 28069-604 WO1 |
| Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
|
Assignee
|
|
|
|
|
| EPTINGERSTRASSE 51 |
| CH-4132 MUTTENZ, SWITZERLAND |
|
|
|
Pat #
|
Pub #
|
Intl #
|
App #
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
11793180
|
|
Correspondence name and address
|
| |
IVOR R. ELRIFI
|
| |
MINTZ, LEVIN, COHN, FERRIS
|
| |
GLOVSKY AND POPEO, P.C.
|
| |
ONE FINANCIAL CENTER
|
| |
BOSTON, MA 02111
|
|
|
Assignment:
2
|
| |
|
| Reel/Frame: | 041072/0269 | |
| Pages: | 23 |
| | Recorded: | 01/23/2017 | | |
| Attorney Dkt #: | PAT056255-US-PCT |
| Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
|
Assignee
|
|
|
|
|
| POSTFACH |
| BASEL, SWITZERLAND 4002 |
|
|
|
Pat #
|
Pub #
|
Intl #
|
App #
|
|
|
|
|
|
|
|
|
|
|
|
|
NONE
|
|
|
15326790
|
|
Correspondence name and address
|
| |
NOVARTIS PHARMACEUTICALS CORPORATION
|
| |
ONE HEALTH PLAZA
|
| |
BUILDING 433
|
| |
EAST HANOVERR, NJ 07936
|
|
|
Assignment:
3
|
| |
|
| Reel/Frame: | 041494/0441 | |
| Pages: | 42 |
| | Recorded: | 01/26/2017 | | |
| Attorney Dkt #: | PAT056255-US-PCT |
| Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
|
Assignee
|
|
|
|
|
| POSTFACH |
| BASEL, SWITZERLAND 4002 |
|
|
|
Pat #
|
Pub #
|
Intl #
|
App #
|
|
|
|
|
|
|
|
|
|
|
|
|
NONE
|
|
|
15326790
|
|
Correspondence name and address
|
| |
NOVARTIS PHARMACEUTICALS CORPORATION
|
| |
ONE HEALTH PLAZA
|
| |
BUILDING 433
|
| |
EAST HANOVER, NJ 07936
|
|
Search Results as of:
05/10/2024 09:36 AM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
